metformin delayed-release (ANJ900)
/ Anji Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 14, 2023
DREAM-T2D: Investigational Study of Delayed Release Metformin
(clinicaltrials.gov)
- P3 | N=675 | Suspended | Sponsor: Anji Pharma | Recruiting ➔ Suspended
Trial suspension • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
June 08, 2022
A Phase 1 Study of ANJ900 Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: Anji Pharma | Active, not recruiting ➔ Completed
Trial completion
1 to 2
Of
2
Go to page
1